Patient-reported outcome measures for life participation in peritoneal dialysis: a systematic review.

Adult Humans Patient Reported Outcome Measures Peritoneal Dialysis / adverse effects Psychometrics Quality of Life
life participation outcome measures peritoneal dialysis

Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
26 04 2021
Historique:
received: 21 01 2020
accepted: 27 07 2020
pubmed: 29 12 2020
medline: 23 7 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Patients receiving peritoneal dialysis (PD) endure an ongoing regimen of daily fluid exchanges and are at risk of potentially life-threatening complications and debilitating symptoms that can limit their ability to participate in life activities. The aim of the study was to identify the characteristics, content and psychometric properties of measures for life participation used in research in PD. We searched MEDLINE, Embase, PsychInfo, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Central Register of Controlled Trials from inception to May 2020 for all studies that reported life participation in patients on PD. The characteristics, dimensions of life participation and psychometric properties of these measures were extracted and analyzed. Of the 301 studies included, 17 (6%) were randomized studies and 284 (94%) were nonrandomized studies. Forty-two different measures were used to assess life participation. Of these, 23 (55%) were used in only one study. Fifteen (36%) measures were specifically designed to assess life participation, while 27 (64%) measures assessed broader constructs, such as quality of life, but included questions on life participation. The 36-Item Short Form Health Survey and Kidney Disease Quality of Life Short Form were the most frequently used measures [122 (41%) and 86 (29%) studies, respectively]. Eight (19%) measures had validation data to support their use in patients on PD. The many measures currently used to assess life participation in patients receiving PD vary in their characteristics, content and validation. Further work to pilot and validate potential measures is required to establish a core patient-reported outcome measure to assess life participation in patients receiving PD.

Sections du résumé

BACKGROUND
Patients receiving peritoneal dialysis (PD) endure an ongoing regimen of daily fluid exchanges and are at risk of potentially life-threatening complications and debilitating symptoms that can limit their ability to participate in life activities. The aim of the study was to identify the characteristics, content and psychometric properties of measures for life participation used in research in PD.
METHODS
We searched MEDLINE, Embase, PsychInfo, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Central Register of Controlled Trials from inception to May 2020 for all studies that reported life participation in patients on PD. The characteristics, dimensions of life participation and psychometric properties of these measures were extracted and analyzed.
RESULTS
Of the 301 studies included, 17 (6%) were randomized studies and 284 (94%) were nonrandomized studies. Forty-two different measures were used to assess life participation. Of these, 23 (55%) were used in only one study. Fifteen (36%) measures were specifically designed to assess life participation, while 27 (64%) measures assessed broader constructs, such as quality of life, but included questions on life participation. The 36-Item Short Form Health Survey and Kidney Disease Quality of Life Short Form were the most frequently used measures [122 (41%) and 86 (29%) studies, respectively]. Eight (19%) measures had validation data to support their use in patients on PD.
CONCLUSIONS
The many measures currently used to assess life participation in patients receiving PD vary in their characteristics, content and validation. Further work to pilot and validate potential measures is required to establish a core patient-reported outcome measure to assess life participation in patients receiving PD.

Identifiants

DOI: 10.1093/ndt/gfaa244 PMID: 33367781 PMC: PMC8075374
pubmed: 33367781
pii: 6050589
doi: 10.1093/ndt/gfaa244
pmc: PMC8075374
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

890-901

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK103972
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Références

Int J Nephrol. 2012;2012:305424
pubmed: 23050149
Saudi J Kidney Dis Transpl. 2009 Mar;20(2):212-8
pubmed: 19237806
Nephrol Dial Transplant. 2016 Jan;31(1):133-41
pubmed: 26346314
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Arch Intern Med. 1997 Jun 23;157(12):1352-6
pubmed: 9201010
Transplantation. 2019 Jun;103(6):1199-1205
pubmed: 30300284
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Rev Lat Am Enfermagem. 2015 May-Jun;23(3):419-26
pubmed: 26312633
BMJ Open. 2019 May 19;9(5):e027776
pubmed: 31110102
Res Q Exerc Sport. 2000 Jun;71 Suppl 2:114-20
pubmed: 25680021
J Pain Symptom Manage. 1997 Feb;13(2):63-74
pubmed: 9095563
Am J Transplant. 2019 Aug;19(8):2306-2317
pubmed: 30664327
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
ANNA J. 1995 Jun;22(3):301-8; discussion 309-10
pubmed: 7786078
Qual Health Care. 1998 Dec;7(4):209-21
pubmed: 10339023
Patient Prefer Adherence. 2018 Apr 19;12:577-583
pubmed: 29720873
Med Care. 1981 Aug;19(8):787-805
pubmed: 7278416
Am J Kidney Dis. 2013 Jun;61(6):873-88
pubmed: 23177729
Trials. 2016 Sep 13;17(1):449
pubmed: 27618914
Nephron. 1992;60(3):302-6
pubmed: 1565182
Am J Occup Ther. 2002 Nov-Dec;56(6):640-9
pubmed: 12458856
Am J Kidney Dis. 2001 Jan;37(1):11-21
pubmed: 11136162
J Nerv Ment Dis. 1996 Jun;184(6):368-74
pubmed: 8642387
J Med Assoc Thai. 2006 Aug;89 Suppl 2:S207-17
pubmed: 17044474
J Clin Epidemiol. 1993 Feb;46(2):153-62
pubmed: 8437031
Transplantation. 2007 Sep 27;84(6):729-37
pubmed: 17893606
Value Health. 2017 Jun;20(6):834-836
pubmed: 28577702
Am J Occup Ther. 2005 Sep-Oct;59(5):569-76
pubmed: 16268024
Arch Phys Med Rehabil. 2011 Jun;92(6):983-97
pubmed: 21621675
Health Psychol. 1990;9(2):117-42
pubmed: 2331973
Transplantation. 2015 Mar;99(3):568-75
pubmed: 25083617
Health Serv Res. 1976 Winter;11(4):430-41
pubmed: 1025052
Health Econ. 1993 Oct;2(3):217-27
pubmed: 8275167
Transplantation. 2017 Aug;101(8):1887-1896
pubmed: 28737661
Kidney Int. 2019 Sep;96(3):699-710
pubmed: 31200941
Clin J Am Soc Nephrol. 2010 Feb;5(2):252-60
pubmed: 20019120
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
Med Care. 1990 Nov;28(11):1056-72
pubmed: 2250492
J Health Serv Res Policy. 1997 Jan;2(1):14-8
pubmed: 10180648
Am J Kidney Dis. 2013 Nov;62(5):953-73
pubmed: 23725972
Disabil Rehabil. 2003 Jun 3-17;25(11-12):565-71
pubmed: 12959329
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
J Clin Oncol. 1984 Mar;2(3):187-93
pubmed: 6699671
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1882-1884
pubmed: 28847909
J Health Econ. 2002 Mar;21(2):271-92
pubmed: 11939242
Soc Sci Med. 2006 Apr;62(8):1891-901
pubmed: 16168542
J Epidemiol Community Health. 1980 Dec;34(4):281-6
pubmed: 7241028
Clin J Am Soc Nephrol. 2006 Nov;1(6):1191-6
pubmed: 17699347
Am J Kidney Dis. 2020 Mar;75(3):404-412
pubmed: 31955922
J Psychosom Res. 1986;30(1):77-91
pubmed: 3701670
Adv Perit Dial. 2009;25:92-5
pubmed: 19886326
Perit Dial Int. 2016 Jan-Feb;36(1):71-8
pubmed: 24711642
J Am Soc Nephrol. 2004 Mar;15(3):743-53
pubmed: 14978177
N Engl J Med. 2010 Dec 23;363(26):2477-81
pubmed: 21142528
Qual Life Res. 1993 Feb;2(1):33-45
pubmed: 8490616
Arch Phys Med Rehabil. 2009 May;90(5):856-66
pubmed: 19406308
Int J Psychiatry Med. 1983-1984;13(4):327-43
pubmed: 6671863
Clin Ter. 2010;161(4):329-33
pubmed: 20931155
Am J Kidney Dis. 2018 Apr;71(4):461-468
pubmed: 29128411
Postgrad Med J. 1987 Dec;63(746):1071-7
pubmed: 3451233
Science. 2004 Dec 3;306(5702):1776-80
pubmed: 15576620

Auteurs

Karine E Manera (KE)

Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Angela Ju (A)

Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Amanda Baumgart (A)

Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Elyssa Hannan (E)

Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Wenjing Qiao (W)

Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Martin Howell (M)

Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Melissa Nataatmadja (M)

Sunshine Coast Hospital and Health Service, Sunshine Coast University Hospital, Kawana Waters, QLD, Australia.

Martin Wilkie (M)

Department of Nephrology, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK.

Fiona Loud (F)

Kidney Care UK, Alton, UK.

Daniel Schwartz (D)

Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Helen Hurst (H)

Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK.

Sarbjit Vanita Jassal (SV)

Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.

Ana Figueiredo (A)

School of Science and Life, Nursing School Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.

Rajnish Mehrotra (R)

Kidney Research Institute and Harborview Medical Center, Division of Nephrology/Department of Medicine, University of Washington, Seattle, WA, USA.

Jenny Shen (J)

Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.

Rachael L Morton (RL)

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

Thyago Moraes (T)

School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.

Rachael Walker (R)

School of Nursing, Eastern Institute of Technology, Hawke's Bay, New Zealand.

Catherine Cheung (C)

Fraser Health Authority, British Columbia, Canada.

Janine F Farragher (JF)

Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

Jonathan Craig (J)

College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.

David W Johnson (DW)

Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Australasian Kidney Trials Network, Centre for Health Services Research, University of Queensland, Brisbane, QLD, Australia.
The Centre for Kidney Disease Research, University of Queensland, Brisbane, QLD, Australia.

Allison Tong (A)

Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Centre for Kidney Research, Children's Hospital at Westmead, Westmead, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Patient-reported outcome measures for life...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Patient-reported outcome measures for life...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes sur les soins de santé › Mesures des résultats rapportés par les patients › Patient-reported outcome measures for life...
questionsmedicales.fr › Thérapeutique › Détoxication par sorption › Dialyse rénale › Dialyse péritonéale › Patient-reported outcome measures for life...
questionsmedicales.fr › Disciplines et activités comportementales › Tests psychologiques › Psychométrie › Patient-reported outcome measures for life...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Patient-reported outcome measures for life...